Atirek portfolio

Sold Berkshire hathway as I feel it might not grow much due to its huge size and us market is not too bad recently. Invest those money by increasing stakes amplitude, alphabet and amazon.

Stocks is now nearly 25 percent of investment as I save most of my incremental money into mutual funds.

Also sold hdfc to buy more of syngene.
Increased stakes in Narayana Health.

Started position in HCG. Again a turnaround play which I am not comportable with but I consider it as a growth stock due to multiple levers of growth due to reducing depreciation, debt and industry structure.

My short analysis about NH
General
Good managment
Ethical management
Permanent trigger for growth
Available at 5 times sales which is on higher side
Long term debt near to cash equivalents
Lowest cost producer
Glassdoor rating is equal to its peers
Profitable
Lifestyle diseases is increasing

Negatives
Need to watch capex types

Industry
Double digit expenditure growth
70 crore of population is under 70 which will change in coming years
Out of pocket expenditure will reduce with insurance. Indian currently has 63 percent out of pocket expenditure when compared to 11 percent in usa.

Rerating
Chances of derating as margin is 20 percent.
Chances of rerating as PE ratio is low compared to competitors

Debt
600 crore of long term, 500 crore of cash.
Not much debt

Current portfolio

1. Amplitude(16.5%)

2. Alphabet(16.5%)

3. Amazon(11.5%)

4. Alibaba(11%)

5. Syngene(19.5%)

6. Maharastra scooters(16%)

7. Narayana Health(4.8%)

8. HCG(4%)0